Cell & gene therapies can replace a lifetime of care with a one-time treatment swapping a lifetime of worry for a lifetime of memories. As we continue to push the boundaries of science to turn ideas into therapies, #Imagine what we can achieve bit.ly/3R2CzFY #WeWontRest

Europe is the slowest region to approve new medicines. With the revision of the #EUPharmaLegislation, policymakers have an opportunity to ensure Europeans benefit from the latest advances in care, without compromising on quality and safety: bit.ly/48PLPnB #WeWontRest

Our aspiration is that all Europeans get access to new medicines on day one after authorisation. How do we make that a reality? Read more on our proposals to ensure faster, more equitable access for patients: bit.ly/48gqraO #WeWontRest

This #WorldHealthDay, let’s #Imagine a world where every patient gets the care they need, when and where they need it. Now we’ve imagined, let’s take action #WeWontRest

With less than one year to go before the EU #HTA Regulation applies, health technology developers are seeking clear guidance to ensure it improves patient #access to innovative #cancer treatments. Read more in our new report: bit.ly/4axuHo4 #WeWontRest